Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation
Bjrnsson ES, Bergmann OM, Bjrnsson HK, Kvaran RB, Olafsson S
Treatment options are extremely limited, and there is no consensus among the medical and scientific communities on how to manage the disease
Akbari J, Saeedi M, Morteza-Semnani K, Hashemi SMH, Babaei A, Eghbali M, et al
doi: 10.1007/s00253-010-3083-4 158
Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair (Bock-Marquette et al., Nature, 2004) Regeneration or Risk